SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Jun-24 4:08 PM View: | Springworks Therapeutics, I... (SWTX) | 03-Jun-24 | Sale (Planned) | 49,000 | $39.90 | $1,955,110.00 | (4%) 1.16M to 1.11M | |
08-Jan-24 9:12 PM View: | Springworks Therapeutics, I... (SWTX) | 08-Jan-24 | Payment of Exercise | 17,904 | $41.53 | $743,553.00 | (7%) 274.17K to 256.26K | |
08-Jan-24 9:12 PM View: | Springworks Therapeutics, I... (SWTX) | 05-Jan-24 | Payment of Exercise | 12,885 | $37.96 | $489,115.00 | (4%) 287.05K to 274.17K | |
08-Jan-24 9:12 PM View: | Springworks Therapeutics, I... (SWTX) | 04-Jan-24 | Grant | 88,000 | -- | -- | 44% 199.05K to 287.05K | |
01-Dec-23 4:01 PM View: | Springworks Therapeutics, I... (SWTX) | 30-Nov-23 | Grant | 199,053 | -- | -- | 100% 0 to 199.05K | |
10-Jan-23 4:07 PM View: | Springworks Therapeutics, I... (SWTX) | 07-Jan-23 | Payment of Exercise | 4,097 | $26.41 | $108,202.00 | (< 1%) 909.2K to 905.1K | |
09-Jan-23 5:01 PM View: | Springworks Therapeutics, I... (SWTX) | 06-Jan-23 | Payment of Exercise | 8,400 | $27.52 | $231,168.00 | (< 1%) 917.6K to 909.2K | |
09-Jan-23 5:01 PM View: | Springworks Therapeutics, I... (SWTX) | 05-Jan-23 | Grant | 84,175 | -- | -- | 10% 833.43K to 917.6K | |
11-Jan-22 4:02 PM View: | Springworks Therapeutics, I... (SWTX) | 07-Jan-22 | Payment of Exercise | 5,893 | $56.06 | $330,362.00 | (< 1%) 857.59K to 851.7K | (5%) |
10-Jan-22 4:31 PM View: | Springworks Therapeutics, I... (SWTX) | 06-Jan-22 | Grant | 78,370 | -- | -- | 10% 779.22K to 857.59K | |
20-Oct-21 7:14 PM View: | Springworks Therapeutics, I... (SWTX) | 20-Oct-21 | Market Sale (Planned) | 10,083 | $58.67 | $591,527.00 | (1%) 789.3K to 779.22K | < 1% |
19-Oct-21 7:27 PM View: | Springworks Therapeutics, I... (SWTX) | 19-Oct-21 | Market Sale (Planned) | 14,077 | $58.81 | $827,873.00 | (2%) 783.21K to 769.13K | < 1% |
19-Oct-21 7:27 PM View: | Springworks Therapeutics, I... (SWTX) | 18-Oct-21 | Market Sale (Planned) | 38,340 | $58.59 | $2,246,510.00 | (5%) 821.55K to 783.21K | < 1% |
20-Jul-21 7:34 PM View: | Springworks Therapeutics, I... (SWTX) | 20-Jul-21 | Market Sale (Planned) | 18,572 | $77.68 | $1,442,750.00 | (2%) 840.12K to 821.55K | 2% |
20-Jul-21 7:34 PM View: | Springworks Therapeutics, I... (SWTX) | 19-Jul-21 | Market Sale (Planned) | 43,928 | $76.09 | $3,342,440.00 | (5%) 884.05K to 840.12K | < 1% |
20-Apr-21 6:51 PM View: | Springworks Therapeutics, I... (SWTX) | 20-Apr-21 | Market Sale (Planned) | 24,075 | $66.39 | $1,598,280.00 | (3%) 908.13K to 884.05K | (2%) |
20-Apr-21 6:51 PM View: | Springworks Therapeutics, I... (SWTX) | 19-Apr-21 | Market Sale (Planned) | 38,425 | $69.04 | $2,652,830.00 | (4%) 946.55K to 908.13K | 2% |
21-Jan-21 4:30 PM View: | Springworks Therapeutics, I... (SWTX) | 20-Jan-21 | Market Sale (Planned) | 2,199 | $78.75 | $173,180.00 | (< 1%) 1.23M to 1.22M | (< 1%) |
21-Jan-21 4:30 PM View: | Springworks Therapeutics, I... (SWTX) | 19-Jan-21 | Market Sale (Planned) | 60,301 | $78.54 | $4,736,210.00 | (5%) 1.29M to 1.23M | (< 1%) |
11-Jan-21 9:28 AM View: | Springworks Therapeutics, I... (SWTX) | 07-Jan-21 | Grant | 37,500 | -- | -- | 3% 1.25M to 1.29M | |
03-Mar-20 6:41 PM View: | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 5,000 | $18.00 | $90,000.00 | 100% 0 to 5.0K | |
01-Mar-16 6:33 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 29-Feb-16 | Market Sale | 905 | $138.91 | $125,714.00 | (2%) 44.7K to 43.8K | (30%) |
08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-16 | Market Sale | 1,474 | $138.07 | $203,518.00 | (3%) 46.18K to 44.7K | (30%) |
08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-16 | Market Sale | 1,970 | $143.48 | $282,661.00 | (4%) 48.15K to 46.18K | (25%) |
08-Feb-16 7:56 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 04-Feb-16 | Grant | 11,763 | -- | -- | 32% 36.38K to 48.15K | |
08-Dec-15 7:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Dec-15 | Market Sale (Planned) | 950 | $190.00 | $180,500.00 | (3%) 37.34K to 36.38K | 5% |
04-Nov-15 5:29 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 02-Nov-15 | Market Sale (Planned) | 975 | $180.00 | $175,500.00 | (3%) 38.31K to 37.34K | < 1% |
29-Oct-15 5:17 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 26-Oct-15 | Market Sale | 1,558 | $168.44 | $262,430.00 | (4%) 39.87K to 38.31K | (7%) |
30-Apr-15 9:45 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Apr-15 | Market Sale | 6,032 | $181.57 | $1,095,230.00 | (13%) 45.9K to 39.87K | < 1% |
03-Mar-15 9:12 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 02-Mar-15 | Market Sale | 228 | $180.34 | $41,117.50 | (< 1%) 39.66K to 39.43K | < 1% |
03-Mar-15 9:12 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 27-Feb-15 | Grant | 5,100 | -- | -- | 15% 34.56K to 39.66K | |
12-Feb-15 9:06 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Feb-15 | Market Sale | 1,500 | $171.15 | $256,725.00 | (4%) 36.06K to 34.56K | (5%) |
09-Feb-15 8:47 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 05-Feb-15 | Grant | 8,760 | -- | -- | 32% 27.3K to 36.06K | |
04-Nov-14 6:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Nov-14 | Option Exercise | 28,125 | $89.23 | $2,509,590.00 | 103% 27.3K to 55.42K | |
04-Nov-14 6:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 03-Nov-14 | Market Option Sale | 28,125 | $190.50 | $5,357,830.00 | (51%) 55.42K to 27.3K | 6% |
04-Mar-14 5:35 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-14 | Grant | 2,300 | -- | -- | 9% 25.0K to 27.3K | |
26-Apr-13 4:29 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 24-Apr-13 | Option Exercise | 25,000 | -- | -- | 100% 0 to 25.0K |